Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/6/15 → 01/11/18 |
Funding
- National Cancer Institute: $1.00
Double-Blind Placebo Controlled Trial of Eflornithine & Sulindac to Prevent Recurrence High Risk Adenomas & Secondary Primary Colorectal Cancers Pts. w/Stage 0-111 Colon Ca - (PACES) Cooperative Study
- Keresztes, Roger (CoPI)
- Choi, Minsig (PI)
- Zhang, Yue (CoPI)
Project: Research